These results show that EA pretreatment can effectively reduce ALI severity and enhance lung function by inhibiting the mRNA and protein expression levels of autophagy-related genes (Beclin 1 and LC3-II/I) in lung tissue. This evidence concerns the gene BECN1 and acute respiratory distress syndrome.